IL4 and Alzheimer disease: Dupilumab, a fully humanized monoclonal antibody that blocks the α-chain of IL-4 and IL-13 receptors, has a good curative effect in adults and children aged 6 years or older with moderate-to-severe AD and has been listed in many countries.15